Appears On
Episode Appearances
Today, Explained · Feb 13, 2026
Skinny and sad on GLP-1s
“NPR pharmaceuticals correspondent providing expert analysis on GLP-1 drug market, compounding pharmacies, and regulatory landscape”
GLP-1 Drug Compounding and Legal RegulationTelehealth Distribution of Weight Loss MedicationsFDA Enforcement Against Illegal Drug Copycat Marketing
View Analysis